D. Zheng

发表

Transcriptome Identified lncRNAs Associated with Renal Fibrosis in UUO Rat Model

Juan Shi, Jiazeng Sun, Shang Zhang, 2017, Front. Physiol..

Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition)

Sangeeta Khare, Xin Qi, Ying Wang, 2016 .

Frequency of HLA-A*03 associates with HIV-1 infection in a Chinese cohort

Y. Ruan, K. Hong, Y. Shao, 2013, Science China Life Sciences.

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury

Mark Chappell, Chengyu Jiang, Guang Liu, 2005, Nature Medicine.

Modulating multidrug resistance through inhibiting of protein kinase C activity by phenothiazines

Hui Peng, Jing Qi, D. Zheng, 1998 .

PRMT5 suppresses DR4-mediated CCL20 release via NF-κB pathway

Min Liu, Dongsheng Wang, D. Zheng, 2012 .

Combination of AAV-TRAIL with miR-221-Zip Therapeutic Strategy Overcomes the Resistance to TRAIL Induced Apoptosis in Liver Cancer

Juan Shi, Yabin Guo, Jiazeng Sun, 2017, Theranostics.

Targeting a Novel N-terminal Epitope of Death Receptor 5 Triggers Tumor Cell Death*

Juan Shi, Ya-xi Zhang, D. Zheng, 2010, The Journal of Biological Chemistry.

Oral adeno‐associated virus‐sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice

Hong Ma, R. Xu, D. Zheng, 2005, Hepatology.

Recombinant adeno‐associated virus‐mediated TRAIL gene therapy suppresses liver metastatic tumors

H. Kung, Xueying Sun, Hong Ma, 2005, International journal of cancer.

A Novel Anti-human DR5 Monoclonal Antibody with Tumoricidal Activity Induces Caspase-dependent and Caspase-independent Cell Death*

Yabin Guo, D. Zheng, Yan-xin Liu, 2005, Journal of Biological Chemistry.

Therapeutic expression of an anti-death receptor 5 single-chain fixed-variable region prevents tumor growth in mice.

Juan Shi, Yabin Guo, R. Xu, 2006, Cancer research.

Formyl peptide receptor-like 1–mediated endogenous TRAIL gene expression with tumoricidal activity

Chentao Lin, D. Zheng, Yan-xin Liu, 2007, Molecular Cancer Therapeutics.

Preclinical evaluation of a novel antibody-drug conjugate targeting DR5 for lymphoblastic leukemia therapy

D. Zheng, Chao Zheng, Shuyong Zhang, 2021, Molecular therapy oncolytics.

The use of folate-PEG-grafted-hybranched-PEI nonviral vector for the inhibition of glioma growth in the rat.

Marie C. M. Lin, H. Kung, X. Shuai, 2009, Biomaterials.

PKCδ protects human breast tumor MCF‐7 cells against tumor necrosis factor‐related apoptosis‐inducing ligand‐mediated apoptosis

D. Zheng, Ning Liu, Yan-xin Liu, 2005, Journal of cellular biochemistry.

A novel humanized anti‐tumor necrosis factor‐related apoptosis‐inducing ligand‐R2 monoclonal antibody induces apoptotic and autophagic cell death

Jiong Cai, D. Zheng, Yan-xin Liu, 2017, IUBMB life.

AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in mice.

Hong Ma, D. Zheng, Yan-xin Liu, 2008, Life sciences.

Knockdown of c‐FLIPL enhanced AD5‐10 anti‐death receptor 5 monoclonal antibody‐induced apoptosis in human lung cancer cells

Ya-xi Zhang, D. Zheng, Yan-xin Liu, 2009, Cancer science.

Functions of miR-146a and miR-222 in Tumor-associated Macrophages in Breast Cancer

Juan Shi, Lianmei Zhao, Bianhua Shi, 2015, Scientific Reports.

TRAIL‐induced miR‐146a expression suppresses CXCR4‐mediated human breast cancer migration

Min Liu, M. Jiang, Dongsheng Wang, 2013, The FEBS journal.

Nucleic Acids in Protein Samples Interfere with Phosphopeptide Identification by Immobilized-Metal-Ion Affinity Chromatography and Mass Spectrometry

Yuan-ming Luo, Youhe Gao, D. Zheng, 2009, Molecular biotechnology.

2A peptide-based, lentivirus-mediated anti-death receptor 5 chimeric antibody expression prevents tumor growth in nude mice.

Juan Shi, Meng Li, D. Zheng, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

An update on gene therapy in China.

Juan Shi, D. Zheng, 2009, Current opinion in molecular therapeutics.

An agonistic monoclonal antibody against DR5 induces ROS production, sustained JNK activation and Endo G release in Jurkat leukemia cells

D. Zheng, Yan-xin Liu, Caifeng Chen, 2009, Cell Research.

TRAIL receptor deficiency sensitizes mice to dextran sodium sulphate‐induced colitis and colitis‐associated carcinogenesis

Juan Shi, D. Zheng, Yan-xin Liu, 2014, Immunology.

8-chloroadenosine induces apoptosis in human MOLT-4 cell line

S. Xiao, Rui Liu, Lihe Zhang, 1997 .

TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4+CD25+ Treg apoptosis

Juan Shi, D. Zheng, Zhijuan Diao, 2013, Cancer Immunology, Immunotherapy.

Epirubicin potentiates recombinant adeno-associated virus type 2/5-mediated TRAIL expression in fibroblast-like synoviocytes and augments the antiarthritic effects of rAAV2/5-TRAIL.

Juan Shi, D. Zheng, Zhijuan Diao, 2012, Arthritis and rheumatism.

A novel anti‐DR5 chimeric antibody and epirubicin synergistically suppress tumor growth

Juan Shi, D. Zheng, Yan-xin Liu, 2012, IUBMB life.

Human T-Cell Leukemia Virus Type 1 Tax-Deregulated Autophagy Pathway and c-FLIP Expression Contribute to Resistance against Death Receptor-Mediated Apoptosis

Juan Shi, Ya-xi Zhang, D. Zheng, 2013, Journal of Virology.

Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma

M. Jiang, Hong Ma, D. Zheng, 2011, BMC Cancer.

A highlight of recent advances in immunology

D. Zheng, 2011, Science China Life Sciences.

Current understanding on the immunological functions of tumor necrosis factor-related apoptosis-inducing ligand.

D. Zheng, Yan-xin Liu, Wei Wei, 2005, Cellular & molecular immunology.

PI3K/Akt signaling pathway involved in regulation of T lymphocyte activation and apoptosis mediated by CD3ε

D. Zheng, Yan-xin Liu, Shi-lian Liu, 2001 .

TRAIL Induces Apoptosis and Autophagy

D. Zheng, Z. Yao, 2016 .

TRAIL Induces Apoptosis and Autophagy TRAIL Induces Apoptosis and Autophagy

D. Zheng, Z. Yao, 2016 .

Sp 1 is involved in 8-chloro-adenosine-upregulated death receptor 5 expression in human hepatoma cells

D. Zheng, Yan-xin Liu, Shi-lian Liu, 2007 .

Tax1 enhances cancer cell proliferation via Ras–Raf–MEK–ERK signaling pathway

Meng Li, D. Zheng, Chunjiao Song, 2009, IUBMB life.

Two tyrosines in CD3s-ITAM are required to induce T lymphocyte apoptosis

S. Xiao, Yiping He, D. Zheng, 1998 .

Tyrosine Mutation in CD3ε–ITAM Blocked T Lymphocyte Apoptosis Mediated by CD3ε

Yiping He, D. Zheng, Yan-xin Liu, 2003 .

Molecular mechanisms of apoptosis induced by CD3ε peptide

D. Zheng, C. Terhorst, Shi-lian Liu, 2002 .

T lymphocyte apoptosis induced by CD8ε chimera

Y. Liu, D. Zheng, Yong Zheng, 1997 .

Cloning and identification of a novel binding protein of CD2 cytoplasmic domain

Dong Li, S. Xiao, D. Zheng, 2000 .

Alpha 1‐antichymotrypsin/SerpinA3 is a novel target of orphan nuclear receptor Nur77

D. Zheng, Yan-xin Liu, Yongjuan Zhao, 2008, The FEBS journal.

GALNT5 uaRNA promotes gastric cancer progression through its interaction with HSP90

Juan Shi, Baoguo Zhou, Juan Shi, 2018, Oncogene.

Dysregulated expression of miR‐146a contributes to age‐related dysfunction of macrophages

M. Jiang, Dongsheng Wang, D. Zheng, 2012, Aging cell.

Tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL)‐induced chemokine release in both TRAIL‐resistant and TRAIL‐sensitive cells via nuclear factor kappa B

Ya-xi Zhang, D. Zheng, Yan-xin Liu, 2009, The FEBS journal.

A double feedback loop mediated by microRNA-23a/27a/24-2 regulates M1 versus M2 macrophage polarization and thus regulates cancer progression

Juan Shi, Min Liu, D. Zheng, 2015, Oncotarget.

p53 predominantly regulates IL-6 production and suppresses synovial inflammation in fibroblast-like synoviocytes and adjuvant-induced arthritis

Juan Shi, Fengchun Zhang, D. Zheng, 2016, Arthritis Research & Therapy.

HIV Infection Enhances TRAIL-Induced Cell Death in Macrophage by Down-Regulating Decoy Receptor Expression and Generation of Reactive Oxygen Species

Juan Shi, D. Zheng, Dan Zhu, 2011, PloS one.

Actinomycin D enhances TRAIL-induced caspase-dependent and -independent apoptosis in SH-SY5Y neuroblastoma cells

D. Zheng, Yan-xin Liu, Shi-lian Liu, 2007, Neuroscience Research.

The molecular mechanism of different sensitivity of breast cancer cell lines to TRAIL

D. Zheng, Yan-xin Liu, Shi-lian Liu, 2004 .

Tumor necrosis factor–related apoptosis-inducing ligand induces the expression of proinflammatory cytokines in macrophages and re-educates tumor-associated macrophages to an antitumor phenotype

Min Liu, M. Jiang, Dongsheng Wang, 2015, Molecular biology of the cell.

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induces chemotactic migration of monocytes via a death receptor 4-mediated RhoGTPase pathway.

Juan Shi, Ya-xi Zhang, Dongsheng Wang, 2010, Molecular immunology.

Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice.

P. Tam, Juan Shi, F. Farzaneh, 2005, Cancer research.

Z-ajoene induces tumor cells to die by apoptosis

Song Zhao, Siqing Zhang, D. Zheng, 1998 .

8-Chloro-adenosine sensitizes a human hepatoma cell line to TRAIL-induced apoptosis by caspase-dependent and -independent pathways.

D. Zheng, Yan-xin Liu, Shi-lian Liu, 2004, Oncology reports.

Mmu-miR-125b overexpression suppresses NO production in activated macrophages by targeting eEF2K and CCNA2

Juan Shi, Lianmei Zhao, D. Zheng, 2016, BMC Cancer.

Dysregulated expression of miR-101b and miR-26b lead to age-associated increase in LPS-induced COX-2 expression in murine macrophage

Min Liu, Jing Gao, M. Jiang, 2015, AGE.

Analysis of the ligand-binding domain of macrophage colony-stimulating receptor

S. Luo, Q. Rao, Ke-fu Wu, 2000 .

Internalization and half-life of membrane-bound macrophage colony-stimulating factor

G. Zheng, Q. Rao, Ke-fu Wu, 2000 .

RIP1 modulates death receptor mediated apoptosis and autophagy in macrophages

Juan Shi, D. Zheng, Z. Yao, 2015, Molecular oncology.

The IncRNA SNHG5/miR‐32 axis regulates gastric cancer cell proliferation and migration by targeting KLF4

Juan Shi, Lianmei Zhao, B. Shan, 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Immunohistochemical observation of macrophage colony stimulating factor and its receptor in breast cancer and hepatoma tissues

Ge Li, Ke-fu Wu, D. Zheng, 2001 .

Death receptor 5‐recruited raft components contributes to the sensitivity of Jurkat leukemia cell lines to TRAIL‐induced cell death

Juan Shi, Ya-xi Zhang, D. Zheng, 2009, IUBMB life.

Adeno-associated virus-mediated anti-DR5 chimeric antibody expression suppresses human tumor growth in nude mice.

Juan Shi, Ya-xi Zhang, D. Zheng, 2011, Cancer letters.

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

Sara W. Bird, Erinna F. Lee, Michael D. Kim, 2016 .

Frequency of HLA-A*03 associates with HIV-1 infection in a Chinese cohort

Y. Ruan, K. Hong, Y. Shao, 2013, Science China Life Sciences.

Therapeutic efficacy of a MMAE-based anti-DR5 drug conjugate Oba01 in preclinical models of pancreatic cancer

J. Liu, D. Zheng, Chao Zheng, 2023, Cell death & disease.

ANTIGEN ASSOCIATION OF J6-1 CE~LL MEMBRANE ASSOCIATED FACTOR. RECEPTOR WITH MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR

G. Zheng, Q. Rao, Ke-fu Wu, 1999 .

Editorial :Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). DOI: 10.1080/15548627.2015.1100356;WOS:000373595400001; 2-s2.0-85013763791&;PMID: 26799652

Lee, Duchen, Izzo, 2016 .

Erbin-regulated sensitivity of MCF-7 breast cancer cells to TRAIL via ErbB2/AKT/NF-kappaB pathway.

D. Zheng, Yan-xin Liu, Shi-lian Liu, 2007, Journal of Biochemistry (Tokyo).

Recombinant sTRAIL induces cell death of tumor cell lines as well as primary cancer cells

D. Zheng, Yan-xin Liu, Z. Ma, 1999 .

Dysregulated expression of miR-101b and miR-26b lead to age-associated increase in LPS-induced COX-2 expression in murine macrophage

Min Liu, M. Jiang, Dongsheng Wang, 2015, AGE.

Molecular therapeutics of HBV.

S. Fan, Hong Ma, R. Xu, 2003, Current gene therapy.

Natural Immunity Enhances the Activity of a DR5 Agonistic Antibody and Carboplatin in the Treatment of Ovarian Cancer

B. Mayer, W. Mikulits, P. Perco, 2010, Molecular Cancer Therapeutics.

A novel anti-DR5 antibody-drug conjugate possesses a high-potential therapeutic efficacy for leukemia and solid tumors

D. Zheng, Chao Zheng, Shuyong Zhang, 2019, Theranostics.

TRAIL receptor mediates inflammatory cytokine release in an NF-κB-dependent manner

Ya-xi Zhang, D. Zheng, Yan-xin Liu, 2009, Cell Research.

Mmu-miR-125b overexpression suppresses NO production in activated macrophages by targeting eEF2K and CCNA2

Juan Shi, Lianmei Zhao, D. Zheng, 2016, BMC Cancer.

Long non-coding RNA SNHG5 suppresses gastric cancer progression by trapping MTA2 in the cytosol

Juan Shi, S. Zhang, Lianmei Zhao, 2016, Oncogene.

Expression of human soluble TRAIL in Chlamydomonas reinhardtii chloroplast

Dong Li, D. Zheng, Yan-xin Liu, 2006 .